Correlation Between Acco Brands and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acco Brands and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acco Brands and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acco Brands and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Acco Brands and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acco Brands with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acco Brands and Regeneron Pharmaceuticals.
Diversification Opportunities for Acco Brands and Regeneron Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Acco and Regeneron is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Acco Brands and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Acco Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acco Brands are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Acco Brands i.e., Acco Brands and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acco Brands and Regeneron Pharmaceuticals
Given the investment horizon of 90 days Acco Brands is expected to under-perform the Regeneron Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Acco Brands is 1.09 times less risky than Regeneron Pharmaceuticals. The stock trades about -0.64 of its potential returns per unit of risk. The Regeneron Pharmaceuticals is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest 77,850 in Regeneron Pharmaceuticals on October 11, 2024 and sell it today you would lose (4,491) from holding Regeneron Pharmaceuticals or give up 5.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Acco Brands vs. Regeneron Pharmaceuticals
Performance |
Timeline |
Acco Brands |
Regeneron Pharmaceuticals |
Acco Brands and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acco Brands and Regeneron Pharmaceuticals
The main advantage of trading using opposite Acco Brands and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acco Brands position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.Acco Brands vs. HNI Corp | Acco Brands vs. Steelcase | Acco Brands vs. Ennis Inc | Acco Brands vs. Acacia Research |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |